NTLA stock

Intellia Therapeutics Inc (NTLA) valuation · rev $67.7M

Intellia Therapeutics Inc (NTLA) rev $67.7M.

Cached valuation scalars
MetricValue
Market cap$1.19B
Revenue$67.7M
P/S17.7
These valuation metrics as JSON? API free 100/day

NTLA valuation FAQ

What is NTLA's market cap?

Intellia Therapeutics Inc (NTLA) market cap is $1.19B on the latest cached fundamentals snapshot.

What is NTLA's latest revenue?

Latest cached Intellia Therapeutics Inc (NTLA) revenue was $67.7M. Statements: https://lician.com/financials/ntla

What is NTLA's price-to-sales ratio?

Intellia Therapeutics Inc (NTLA) price-to-sales (P/S) is 17.7, cached market cap $1.19B divided by revenue $67.7M.

How many NTLA valuation scalars are listed on this page?

This page lists 3 cached valuation scalars for Intellia Therapeutics Inc (NTLA): Market cap, Revenue, and P/S.

Where is NTLA valuation listed?

Cached valuation multiples for Intellia Therapeutics Inc (NTLA) are listed at https://lician.com/valuation/ntla.

Not investment advice. Cached rows, not a live tape.